Acadia Healthcare (ACHC) reported Q4 adjusted diluted earnings Thursday of $0.64, down from $0.85 a year earlier.
Analysts polled by FactSet expected $0.71.
Revenue for the quarter ended Dec. 31 was $774.2 million, up from $742.8 million.
Analysts surveyed by FactSet expected $779 million.
The company said it expects Q1 revenue of $765 million to $775 million.
Analysts polled by FactSet expect $820.6 million.
For the full year 2025, the company expects adjusted EPS of $2.50 to $2.80 on $3.3 billion to $3.4 billion in revenue.
Analysts surveyed by FactSet expect $3.35 on revenue of $3.43 billion.
Additionally, Acadia said its board authorized a share repurchase program of up to $300 million for the company's outstanding common stock.
Shares of Acadia Healthcare were down over 14% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.